The Effectiveness of carbetocin in the treatment of sows with postpartum diseases

Reproductive well-being is the foundation of any enterprise's reproduction. The success of livestock farming depends on the quality of the offspring and the preservation of the productivity of the breeding stock. The postpartum period plays a crucial role in maintaining the physiological health of sows. The farrowing process involves the mobilization of all the mother's body systems and the expenditure of significant energy. The purpose of the study is to conduct a comparative assessment of the effectiveness of myotropic drugs used with carbetocin in the therapeutic treatment of highly productive sows with signs of postpartum uterine and mammary gland inflammatory diseases. To achieve this, the frequency of drug administration, the milk production of sows, the survival rate of piglets at weaning, the duration of the non-productive period, and the fertility rate were analyzed. To conduct the experiment, 3 groups (n=10) of similar sows with clinical signs of the disease were formed. Similar groups were formed for the diagnosis of postpartum endometritis. In the first group of sows, the prolonged drug Rutocin (with the active ingredient carbetocin 0.07 mg/ml) was used at a dosage of 1.0 ml/head. In the second group, the sows were administered Uteroton (based on propranolol hydrochloride 5 mg/ml) at a dosage of 5 ml/head. In the third group, the sows were treated with the hormonal drug Oxytocin at a dosage of 20 IU/head. The results of the conducted studies showed that the duration of treatment is reduced and reproductive indicators are improved when using carbetocin in the treatment of sows with postpartum dysgalactia and postpartum endometritis.